EGRIFTA SV
NDC 62064-241, tesamorelin, kit, from Theratechnologies Inc..
- Product NDC
- 62064-241
- Status
- Listed
- Labeler
- Theratechnologies Inc.
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA022505
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62064-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62064-241-30 | 62064024130 | 1 KIT in 1 BOX (62064-241-30) * .5 mL in 1 VIAL * 30 BOTTLE in 1 TRAY / 10 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3d783378-b02d-4f19-99dd-0fc91a042224
Use it
Look up 62064-241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62064-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62064-241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.